Cargando…

Improved synthesis of [(18)F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors

PURPOSE: Dopamine receptors are involved in pathophysiology of neuropsychiatric diseases, including Huntington’s disease (HD). PET imaging of dopamine D2 receptors (D2R) in HD patients has demonstrated 40% decrease in D2R binding in striatum, and D2R could be a reliable quantitative target to monito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huhtala, Tuulia, Poutiainen, Pekka, Rytkönen, Jussi, Lehtimäki, Kimmo, Parkkari, Teija, Kasanen, Iiris, Airaksinen, Anu J., Koivula, Teija, Sweeney, Patrick, Kontkanen, Outi, Wityak, John, Dominiquez, Celia, Park, Larry C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682833/ https://www.ncbi.nlm.nih.gov/pubmed/31659519 http://dx.doi.org/10.1186/s41181-019-0071-6

Ejemplares similares

The Urine Metabolome of R6/2 and zQ175DN Huntington’s Disease Mouse Models
por: Speziale, Roberto, et al.
Publicado: (2023)

Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease
por: Heikkinen, Taneli, et al.
Publicado: (2012)

Longitudinal investigation of changes in resting-state co-activation patterns and their predictive ability in the zQ175 DN mouse model of Huntington’s disease
por: Adhikari, Mohit H., et al.
Publicado: (2023)

Impaired Performance of the Q175 Mouse Model of Huntington’s Disease in the Touch Screen Paired Associates Learning Task
por: Piiponniemi, Tuukka O., et al.
Publicado: (2018)

Abnormal Brain Development in Huntington’ Disease Is Recapitulated in the zQ175 Knock-In Mouse Model
por: Zhang, Chuangchuang, et al.
Publicado: (2020)

Enhanced GABAergic Inhibition of Cholinergic Interneurons in the zQ175(+/−) Mouse Model of Huntington's Disease
por: Lim, Sean Austin O., et al.
Publicado: (2021)

Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HD
por: Curtin, Paul C. P., et al.
Publicado: (2016)

Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease
por: Sanchis, Ana, et al.
Publicado: (2019)

Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches
por: Smith, Edward J, et al.
Publicado: (2023)

Global Rhes knockout in the Q175 Huntington’s disease mouse model
por: Heikkinen, Taneli, et al.
Publicado: (2021)

Genetic Deletion of Transglutaminase 2 Does Not Rescue the Phenotypic Deficits Observed in R6/2 and zQ175 Mouse Models of Huntington's Disease
por: Menalled, Liliana B., et al.
Publicado: (2014)

Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175
por: Menalled, Liliana B., et al.
Publicado: (2012)

Search for t to Zq
por: CMS Collaboration
Publicado: (2012)

The Population Genetics of dN/dS
por: Kryazhimskiy, Sergey, et al.
Publicado: (2008)

Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington’s disease
por: Heikkinen, Taneli, et al.
Publicado: (2020)

[(18)F]fallypride characterization of striatal and extrastriatal D(2/3) receptors in Parkinson's disease
por: Stark, Adam J., et al.
Publicado: (2018)

Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington’s Disease
por: Peng, Qi, et al.
Publicado: (2016)

Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington’s Disease Knock-in Mice
por: Schindler, Franziska, et al.
Publicado: (2021)

Optimising Golgi–Cox staining for use with perfusion-fixed brain tissue validated in the zQ175 mouse model of Huntington's disease
por: Bayram-Weston, Zubeyde, et al.
Publicado: (2016)

Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum
por: Pinchaud, Katleen, et al.
Publicado: (2023)

Characterization of HTT Inclusion Size, Location, and Timing in the zQ175 Mouse Model of Huntington´s Disease: An In Vivo High-Content Imaging Study
por: Carty, Nikisha, et al.
Publicado: (2015)

Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington’s Mice
por: Li, Si Han, et al.
Publicado: (2022)

Small Molecule Pytren-4QMn Metal Complex Slows down Huntington’s Disease Progression in Male zQ175 Transgenic Mice
por: Merino, Marián, et al.
Publicado: (2023)

dN/dEta measurement at different multiplicities in ALICE
por: Liu, Xiaoyu
Publicado: (2016)

The Influence of Selection for Protein Stability on dN/dS Estimations
por: Dasmeh, Pouria, et al.
Publicado: (2014)

Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington’s pathology in zQ175 mice
por: Abd-Elrahman, Khaled S., et al.
Publicado: (2019)

A mixed fixed ratio/progressive ratio procedure reveals an apathy phenotype in the BAC HD and the z_Q175 KI mouse models of Huntington’s disease
por: Oakeshott, Stephen, et al.
Publicado: (2012)

Extensive Expression Analysis of Htt Transcripts in Brain Regions from the zQ175 HD Mouse Model Using a QuantiGene Multiplex Assay
por: Papadopoulou, Aikaterini S., et al.
Publicado: (2019)

Multi-GBq production of the radiotracer [(18)F]fallypride in a droplet microreactor
por: Wang, Jia, et al.
Publicado: (2020)

The Impact of Recombination on dN/dS within Recently Emerged Bacterial Clones
por: Castillo-Ramírez, Santiago, et al.
Publicado: (2011)

Why Time Matters: Codon Evolution and the Temporal Dynamics of dN/dS
por: Mugal, Carina F., et al.
Publicado: (2014)

[(18)F]fallypride-PET/CT Analysis of the Dopamine D(2)/D(3) Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection
por: Mann, Teresa, et al.
Publicado: (2018)

Exercise against cocaine sensitization in mice: a [(18)F]fallypride micro-PET study
por: Becker, Guillaume, et al.
Publicado: (2021)

Study of ATLAS Sensitivity to FCNC TOP Quark Decay $t \to Zq$
por: Chikovani, Leila, et al.
Publicado: (2000)

ATLAS Sensitivity to the Flavour-Changing Neutral Current Decay $t \to Zq$
por: Chikovani, Leila, et al.
Publicado: (2002)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [(18)F] fluspidine and [(18)F] fallypride PET study
por: Grachev, Igor D., et al.
Publicado: (2020)

High training volume is associated with increased prevalence of non-allergic asthma in competitive cross-country skiers
por: Mäki-Heikkilä, Rikhard, et al.
Publicado: (2022)

Acute respiratory infections hamper training and competition in cross-country skiers, especially in those with asthma
por: Mäki-Heikkilä, Rikhard, et al.
Publicado: (2023)

Measuring the distribution of fitness effects in somatic evolution by combining clonal dynamics with dN/dS ratios
por: Williams, Marc J, et al.
Publicado: (2020)

Long-term Mortality among Patients with Chronic Ulcers
por: SALENIUS, Jenni E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9b4a852pfu66t6vd2mebhsjv0m